.FDA declines experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Authorize MDMA Treatment, Seeking Additional Study The Nyc TimesFDA Turns Down Ecstasy-Based Medicine The Stock market JournalFDA declines to authorize unfamiliar MDMA therapy to manage PTSD, with request for additional litigation data CNNFDA refuses first psychedelic to handle post-traumatic stress disorder, requiring even more research The Washington Post.